AP4 is required for mitogen- and c-MYC-induced cell cycle progression

Area of Science:

• Molecular Biology
• Cell Biology
• Cancer Research

Background:

• AP4 (a transcription factor) is upregulated in various tumors.
• c-MYC is a known oncogene involved in cell proliferation.

Purpose of the Study:

• To investigate the role of AP4 in cell cycle regulation and proliferation.
• To determine if AP4 is a mediator of c-MYC's effects on cell cycle progression.

Main Methods:

• Utilized AP4-deficient mouse embryo fibroblasts (MEFs).
• Assessed cell proliferation, cell cycle phase entry, and DNA damage.
• Investigated the expression of CDK2 (cyclin-dependent kinase 2).
• Employed AP4-ER fusion protein to study AP4 activation.

Main Results:

• AP4-deficient MEFs showed impaired proliferation, delayed S-phase entry, and cytokinesis defects.
• AP4 is essential for c-MYC-induced cell cycle re-entry.
• AP4 directly regulates CDK2 expression.
• AP4 deficiency led to increased DNA damage and reduced c-MYC-induced apoptosis.

Conclusions:

• AP4 is a key mediator of cell cycle progression in response to mitogenic signals and c-MYC.
• AP4 plays a role in coordinating cell cycle and DNA damage response.
• Inhibiting AP4 may be a viable strategy for blocking tumor cell proliferation.